Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • ATVB Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Cover Art Award
    • ATVB Early Career Award
    • ATVB in Focus
    • Recent Brief Reviews of ATVB
    • Lecture Series
    • Collections
    • Recent Highlights of ATVB
    • Commentaries
    • Browse Abstracts
    • Insight into ATVB Authors
  • Resources
    • Instructions for Authors
    • Online Submission/Peer Review Site
    • Council on ATVB
    • Permissions and Rights Q&A
    • AHA Guidelines and Statements
    • Customer Service and Ordering Information
    • Author Reprints
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • LinkedIn
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Arteriosclerosis, Thrombosis, and Vascular Biology

  • My alerts
  • Sign In
  • Join

  • Facebook
  • LinkedIn
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • ATVB Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Cover Art Award
    • ATVB Early Career Award
    • ATVB in Focus
    • Recent Brief Reviews of ATVB
    • Lecture Series
    • Collections
    • Recent Highlights of ATVB
    • Commentaries
    • Browse Abstracts
    • Insight into ATVB Authors
  • Resources
    • Instructions for Authors
    • Online Submission/Peer Review Site
    • Council on ATVB
    • Permissions and Rights Q&A
    • AHA Guidelines and Statements
    • Customer Service and Ordering Information
    • Author Reprints
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Letters to the Editor

Reactive Hyperemia Revisited

Daniela Calderaro, Maristela C. Monachini, Carolina L.Z. Vieira, Pai Ching Yu, Danielle M. Gualandro, Andre C. Marques, Bruno Caramelli
Download PDF
https://doi.org/10.1161/ATVBAHA.107.158931
Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:e23-e24
Originally published March 19, 2008
Daniela Calderaro
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maristela C. Monachini
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carolina L.Z. Vieira
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pai Ching Yu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Danielle M. Gualandro
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andre C. Marques
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruno Caramelli
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Info & Metrics
  • eLetters

Jump to

  • Article
    • Acknowledgments
    • References
  • Figures & Tables
  • Info & Metrics
  • eLetters
Loading

To the Editor:

We read with great interest Dr Huang’s study, published in Arteriosclerosis, Thrombosis, and Vascular Biology.1 We are in total agreement with the authors about the clinical relevance in the perioperative setting of the hyperemic flow velocity, measured by brachial artery Doppler ultrasound. Dr Huang suggests that reactive hyperemia increases the accuracy of the noninvasive vascular reactivity test, namely the brachial artery flow-mediated dilation, in predicting cardiovascular events after major vascular surgery, even though in his patients the strongest isolated predictor was flow-mediated dilation.

In a population of 96 vascular surgical patients, we assessed brachial artery flow-mediated dilation and reactive hyperemia with the same technique as Dr Huang’s before major vascular surgery was performed, with a Siemens ultrasound system (Sequoia), equipped with a 7.5-mHz vascular transducer. The brachial artery ultrasound was always performed in the morning, after a 6-hour fast and at least 12 hours without smoking. Patients received all medications, including statins, and remained resting in supine position 15 minutes before the beginning until the end of the examination. We acquired 2-dimensional ultrasound images of the brachial artery and pulsed Doppler signals above the antecubital crease at baseline and during a period of reactive hyperemia induced by 5-minute cuff occlusion of the upper arm, at a 250-mm Hg pressure. After at least a 10-minute rest period, for restoration of baseline conditions, we reassessed the brachial artery image and blood flow, before and 3 minutes after administration of sublingual isosorbide dinitrate (5 mg). Images of the brachial artery were recorded at baseline and during the first 2 minutes after relief of the upper-arm occlusion for assessment of the flow-mediated response and before and 3 minutes after nitrate administration. Flows were recorded at baseline and during the first 15 seconds after cuff release, for assessment of the peak reactive hyperemia. Analysis were performed offline, by the same investigator, who was blinded to clinical outcomes. He used an automatized software that calculated for each phase of the examination, the mean diameter of 6 images of the brachial artery. Images were acquired with simultaneous record of ECG and the diameter was measured at the end-diastole (peak R, on the EKG). Hyperemic blood flow velocity was measured online by ultrasound. Flow mediated dilation (FMD) was calculated as the difference between diameters before and after reactive hyperemia in relation to the baseline artery diameter, expressed as percentage.

Although Huang et al did not report cardiac risk estimation according to some specific algorithm, we consider that our population risk profile is comparable to theirs, as the mean ages are very similar and the prevalence of coronary artery disease is the same in both populations: 38%. Moreover, if we dichotomize the flow mediated dilation response, defining as normal FMD >8.0%,2 we have 67% of Huang’s patients and 70% of ours with endothelial dysfunction, almost the same. The prevalence of hypertension, history of smoking, and aspirin therapy are high in both studies. We believe that a significant difference that has to be emphasized resides in the lipid lowering therapy: 54% in Huang’s patients and 98% in ours (Table).

View this table:
  • View inline
  • View popup

Table. Baseline Characteristics and Brachial Ultrasound Results

We detected events in 27 patients during 1-month follow-up period: 4 cardiovascular deaths, 5 myocardial infarctions, 2 isolated troponin elevations, 2 ischemic strokes, 1 pulmonary embolism, 2 reoperations, and 11 noncardiac deaths (3 hemorrhagic shock, 4 sepsis, 4 seconds SIRS). Differently from Huang’s study, we did not find significant difference in the flow-mediated dilation between patients with and without events: 5.88±6.00%×4.83±6.81% (P=0.46), respectively. Excluding noncardiovascular events from the analysis, the nonsignificant difference in the flow-mediated dilation of the brachial artery persisted (P=0.96). Interesting however, we found that lower hyperemic flow velocity predicted perioperative events: 81 cm/s ±20×95 cm/s ±28 (P=0.02). When we analyzed the association between hyperemic flow velocity and cardiovascular events, we found: 80 cm/s ±22×95 cm/s ±28 (P=0.09), for patients with and without events, respectively, possibly because of the lower number of events analyzed.

The lower hyperemic flow velocity observed in our patients with events could not be attributed to age, sex, diabetes, hypertension, or congestive heart failure (unpublished data, Calderaro D, Monachini MC, Vieira CLZ, Yu PC, Gualandro DM, Marques AC, Caramelli B, 2007).

We believe that statin therapy prescribed for the majority of our patients might have altered the vascular reactivity and might have decreased the association of flow-mediated dilation to cardiovascular events, justifying at least partially why we did not reproduce this association. Mitchell et al3 have already shown that lipid lowering therapy lost its association to FMD when reactive hyperemia was considered in the stepwise regression analysis. We hypothesized that lipid lowering therapy modifies the parameter of vascular reactivity mostly related to cardiovascular risk factors from FMD to reactive hyperemia.

In addition to Dr Huang’s study, our findings indicate that hyperemic flow velocity, as a marker of the vascular shear stress and directly related to the microvascular function, should be reported and analyzed routinely whenever this vascular reactivity test is performed. Actually, more than a simple stimulus for endothelial function evaluation, reactive hyperemia provides a better understanding of the vascular biology and pathophysiology of atherosclerosis.4 Moreover, differently from Dr Huang’s findings, our data suggest that reactive hyperemia could be even a better predictor of cardiovascular events in specific populations or particular settings.

Acknowledgments

Disclosures

None.

References

  1. ↵
    Huang AL, Silver AE, Shvenke E, Schopfer DW, Jahangir E, Titas MA, Shpilman A, Menzoian JO, Watkins MT, Raffetto JD, Gibbons G, Woodson J, Shaw PM, Dhadly M, Eberhardt RT, Keaney JF Jr, Gokce N, Vita JA. Predictive value of reactive hyperemia for cardiovascular events in patients with peripheral arterial disease undergoing vascular surgery. Arterioscler Thromb Vasc Biol. 2007; 27: 2113–2119.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    Coretti MC, Anderson T, Benjamin E, Celermajer D. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. A report of the international brachial artery reactivity task force. J Am Coll Cardiol. 2002; 39: 257–265.
    OpenUrlCrossRefPubMed
  3. ↵
    Mitchell GF, Parise H, Vita JA, Larson MG, Warner E, Keaney JF Jr, Keyes MJ, Levy D, Vasan RS, Benjamin EJ. Local shear stress and brachial artery flow-mediated dilation: the Framingham Heart Study. Hypertension. 2004; 44: 134–139.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Pyke KE, Tschakovsky ME. The relationship between shear stress and flow-mediated dilatation: implications for the assessment of endothelial function. J Physiol. 2005; 568 (Pt 2): 357–369.
    OpenUrlCrossRefPubMed
View Abstract
Back to top
Previous ArticleNext Article

This Issue

Arteriosclerosis, Thrombosis, and Vascular Biology
April 2008, Volume 28, Issue 4
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • Acknowledgments
    • References
  • Figures & Tables
  • Info & Metrics
  • eLetters

Article Tools

  • Print
  • Citation Tools
    Reactive Hyperemia Revisited
    Daniela Calderaro, Maristela C. Monachini, Carolina L.Z. Vieira, Pai Ching Yu, Danielle M. Gualandro, Andre C. Marques and Bruno Caramelli
    Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:e23-e24, originally published March 19, 2008
    https://doi.org/10.1161/ATVBAHA.107.158931

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Arteriosclerosis, Thrombosis, and Vascular Biology.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Reactive Hyperemia Revisited
    (Your Name) has sent you a message from Arteriosclerosis, Thrombosis, and Vascular Biology
    (Your Name) thought you would like to see the Arteriosclerosis, Thrombosis, and Vascular Biology web site.
  • Share on Social Media
    Reactive Hyperemia Revisited
    Daniela Calderaro, Maristela C. Monachini, Carolina L.Z. Vieira, Pai Ching Yu, Danielle M. Gualandro, Andre C. Marques and Bruno Caramelli
    Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:e23-e24, originally published March 19, 2008
    https://doi.org/10.1161/ATVBAHA.107.158931
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Arteriosclerosis, Thrombosis, and Vascular Biology

  • About ATVB
  • AHA CME
  • Meeting Abstracts
  • Permissions
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Contact the Editorial Office:
email: atvb@atvb.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured